Description

n-(8-Bromo-1-(6-(2-Cyanopropan-2-Yl)Pyridin-3-Yl)-1H-Imidazo[4,5-C]Quinolin-2(3H)-Ylidene)Cyanamide (Wxg01417) is a high-purity, advanced pharmaceutical intermediate with the CAS registry number 1879084-17-9. This compound is a critical building block in modern medicinal chemistry, valued for its complex heterocyclic structure that serves as a core scaffold for drug discovery. It is primarily utilized by research institutions and pharmaceutical companies engaged in the development of novel therapeutic agents, particularly in oncology and antiviral research.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of targeted small-molecule drugs, especially kinase inhibitors.
• Medicinal Chemistry Research: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Oncology Drug Development: Used in the research and development of potential anticancer agents due to its imidazoquinoline core.
• Antiviral Compound Synthesis: Employed in creating novel compounds for screening against viral targets.
• Biochemical Tool Compound: Acts as a reference standard or probe in biochemical and cellular assays to study specific biological pathways.
• Contract Research & Manufacturing (CRO/CMO): Supplied to service organizations supporting pharmaceutical R&D and scale-up activities.

Basic Information

Product Name	n-(8-Bromo-1-(6-(2-Cyanopropan-2-Yl)Pyridin-3-Yl)-1H-Imidazo[4,5-C]Quinolin-2(3H)-Ylidene)Cyanamide (Wxg01417)
CAS No.	1879084-17-9
Molecular Formula	C₂₁H₁₄BrN₇
Molecular Weight	460.29 g/mol
Synonyms	Wxg01417; 8-Bromo-1-[6-(2-cyano-2-propanyl)-3-pyridinyl]-1H-imidazo[4,5-c]quinolin-2(3H)-ylidene]cyanamide; 1879084-17-9; n-(8-Bromo-1-(6-(2-cyanopropan-2-yl)pyridin-3-yl)-1H-imidazo[4,5-c]quinolin-2(3H)-ylidene)cyanamide; Imidazo[4,5-c]quinoline derivative Wxg01417; Bromo-imidazoquinoline cyanamide intermediate
EINECS	Contact for details

Quality Control

Our n-(8-Bromo-1-(6-(2-Cyanopropan-2-Yl)Pyridin-3-Yl)-1H-Imidazo[4,5-C]Quinolin-2(3H)-Ylidene)Cyanamide (Wxg01417) is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing all specifications are provided and available upon request, supporting compliance with cGMP guidelines for advanced pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is moisture-sensitive; keep the container tightly sealed in a dry environment. For long-term storage, consider storing under an inert atmosphere.

Specification

Item	Specification
Appearance	Off-white to light yellow solid
Identification (HPLC)	Conforms
Identification (MS)	Conforms
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.